Last week, three companies made debuts on public exchanges, raising a total of $801.9 million, mostly on the back of the year’s largest biotech IPO in Moderna Therapeutics. Synthorx, a San Diego biopharmaceutical company joins Moderna as the two healthcare IPOs last week. Rounding out the three is MOGU, Inc., a Chinese online retailer of fashion and cosmetics goods.
Volatility Again Creates Uncertainty in the IPO Market, Potentially Delaying Major 2019 Debuts12/1/2018
According to preliminary data provided by Pitchbook, only six firms went public in November 2018, raising a total of $262 million in funding. Total IPOs and funds raised are down 68.4% and 92.5%, respectively, from October. Furthermore, there were three less IPOs this November than one year prior and 80% less capital raised.
Last week, the lone company to go public, TuanChe, a Chinese automotive e-commerce company, raised $20 million. While last week was slow for IPOs, 2019 is anticipated to be the exact opposite. A handful of Silicon Valley’s largest constituents are slated for public offerings, with a few aiming for valuations in the twelve-figure range. Uber, Lyft, Airbnb, and WeWork are headlining the group of Unicorns expected to go public.
Last week, four private companies made the jump to go public, consisting of two financial companies and two healthcare companies. In total, the four companies – Eton Pharmaceuticals, Vapotherm, Weidai, and Bain Capital Specialty Finance – raised $282.9 million in financing, according to Pitchbook. Bain Capital Specialty Finance, the largest of the IPOs, raised $151.9 million in a spin-off of Bain Capital’s middle market business development division.
Sixteen companies went public on the Nasdaq and New York Stock Exchange in October, raising a total of $3.3 billion, or 7.5% more than the previous month. On an annualized basis, there was a 65.6% increase in capital raised from one year prior on four more IPOs.
Last week, three health care companies made their Nasdaq trading debut, raising a total of $390 million in equity capital. Twist Bioscience and Axonics Modulation Technologies, both from California, along with Orchard Therapeutics from London, debuted their initial public offerings despite a volatile couple weeks in the stock market.
New York Stock Exchange data shows that only four firms debuted on the U.S. public exchanges last week. The group raised a total of $1.6 billion, most of which came on the back of StoneCo’s $1.2 billion IPO. Other market first-timers include Pintec Technology and Gamida Cell. Also making headlines, Cloudflare announced its preparations for a $3.5 billion 2019 public debut.
Per the New York Stock Exchange website, seven firms priced their IPOs last week, raising a combined $1.08 billion in capital. Four of the newly public firms are healthcare-focused companies, and they raised a total of $287 million. The largest IPO was the lone IT firm, SolarWinds, which raised $375 million.
According to data provided on the New York Stock Exchange website, a total of four U.S. companies listed on U.S. exchanges last week, raising just over $1 billion in total funding. The debuts included two healthcare companies, Equillium and Allogene, one business-to-business SaaS firm, Anaplan, and one industrial metals firm, Livent.
According to data provided by the New York Stock Exchange, four IPOs listed on the Nasdaq or NYSE last week. In total, the firms raised $830.3 million through share sales. All four companies are based in Silicon Valley and were previously backed by venture capitalists.
|
Archives
May 2023
Categories
All
|